{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:42:56Z","timestamp":1776652976792,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Post-contrast FLAIR MRI can demonstrate meningeal signal enhancement in people with multiple sclerosis (pwMS), including enhancement along the leptomeninges and dura mater. Although these enhancement patterns have been variably interpreted as reflecting inflammatory processes, their biological specificity and relationship to cortical lesion pathology remain uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the association between cortical lesion burden and distinct patterns of meningeal enhancement (ME), including dura mater enhancement (DME), leptomeningeal enhancement (LME), and meningeal perivascular enhancement (MPVE) on MRI in pwMS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>214 pwMS (173 relapsing\u2013remitting, 41 progressive) underwent 3T MRI including 3D FLAIR pre- and post-contrast, and subtraction imaging. ME (LME\u2009+\u2009DME) and MPVE were visually classified. Cortical lesions were quantified using a validated multi-modal approach incorporating MMCLE, FLAIR-squared, AI-DIR, and T1\/T2 ratio maps, with expert verification. Analyses were adjusted for age, sex, disease duration, disease subtype, and disease-modifying treatment, and corrected for multiple comparisons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      142 (66.4%) pwMS showed combined ME\/MPVE, 121 (56.5%) ME, including 97 (45.3%) with DME and 48 (22.4%) with LME. Additionally, 46 (21.5%) exhibited MPVE. A higher prevalence and frequency of LME\u2009+\u2009pwMS were observed in older age groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002), whereas no such age-related pattern was found for DME\u2009+\u2009or MPVE\u2009+\u2009pwMS. DME\u2009+\u2009pwMS showed greater cortical lesion number (9.6 vs. 4.9,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.003) and volume (374.1 mm\n                      <jats:sup>3<\/jats:sup>\n                      vs. 187.6 mm\n                      <jats:sup>3<\/jats:sup>\n                      ,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.019) compared to DME \u2212 pwMS. DME frequency correlated with cortical lesion number (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.59,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and volume (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.56,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Stepwise regression identified DME as an independent predictor of cortical lesion number (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u20090.45,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and volume (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009=\u20090.41,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), explaining 12\u201315% of variance beyond conventional MRI measures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>DME on 3T MRI is associated with increased cortical lesion burden in pwMS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-026-13781-6","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:29:26Z","timestamp":1775478566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dura mater enhancement on 3T MRI is associated with cortical lesion burden in multiple sclerosis"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7799-1485","authenticated-orcid":false,"given":"Robert","family":"Zivadinov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehak","family":"Semy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Bartnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska E.","family":"Hildesheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Tranquille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dejan","family":"Jakimovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hojnacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Weinstock-Guttman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael G.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Bergsland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"13781_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1212\/WNL.0000000000001587","volume":"85","author":"M Absinta","year":"2015","unstructured":"Absinta M, Vuolo L, Rao A et al (2015) Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis. Neurology 85:18\u201328","journal-title":"Neurology"},{"key":"13781_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2022.102939","volume":"33","author":"BV Ineichen","year":"2022","unstructured":"Ineichen BV, Tsagkas C, Absinta M, Reich DS (2022) Leptomeningeal enhancement in multiple sclerosis and other neurological diseases: a systematic review and meta-analysis. Neuroimage Clin 33:102939","journal-title":"Neuroimage Clin"},{"key":"13781_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.nic.2024.03.007","volume":"34","author":"R Zivadinov","year":"2024","unstructured":"Zivadinov R, Schweser F, Jakimovski D, Bergsland N, Dwyer MG (2024) Decoding gray matter involvement in multiple sclerosis via imaging. Neuroimaging Clin N Am 34:453\u2013468","journal-title":"Neuroimaging Clin N Am"},{"key":"13781_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/jamaneurol.2016.4237","volume":"74","author":"J Zurawski","year":"2017","unstructured":"Zurawski J, Lassmann H, Bakshi R (2017) Use of magnetic Resonance imaging to visualize leptomeningeal inflammation in patients with multiple sclerosis: a review. JAMA Neurol 74:100\u2013109","journal-title":"JAMA Neurol"},{"key":"13781_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae359","volume":"6","author":"DM Harrison","year":"2024","unstructured":"Harrison DM, Sati P, Klawiter EC et al (2024) The use of 7T MRI in multiple sclerosis: review and consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Brain Commun 6:fcae359","journal-title":"Brain Commun"},{"key":"13781_CR6","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1177\/13524585231199031","volume":"29","author":"M Vercellino","year":"2023","unstructured":"Vercellino M, Costantini G, Cogoni M et al (2023) Association of MRI leptomeningeal enhancement with disability worsening in progressive multiple sclerosis: a clinical and post-mortem study. Mult Scler 29:1526\u20131539","journal-title":"Mult Scler"},{"key":"13781_CR7","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1212\/WNL.0000000000003820","volume":"88","author":"M Absinta","year":"2017","unstructured":"Absinta M, Cortese IC, Vuolo L et al (2017) Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases. Neurology 88:1439\u20131444","journal-title":"Neurology"},{"key":"13781_CR8","first-page":"620","volume":"40","author":"N Bergsland","year":"2019","unstructured":"Bergsland N, Ramasamy D, Tavazzi E, Hojnacki D, Weinstock-Guttman B, Zivadinov R (2019) Leptomeningeal contrast enhancement is related to focal cortical thinning in relapsing-remitting multiple sclerosis: a cross-sectional MRI study. AJNR Am J Neuroradiol 40:620\u2013625","journal-title":"AJNR Am J Neuroradiol"},{"key":"13781_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102653","volume":"47","author":"FE Hildesheim","year":"2021","unstructured":"Hildesheim FE, Ramasamy DP, Bergsland N et al (2021) Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis. Mult Scler Relat Disord 47:102653","journal-title":"Mult Scler Relat Disord"},{"key":"13781_CR10","doi-asserted-by":"publisher","first-page":"8652463","DOI":"10.1155\/2017\/8652463","volume":"2017","author":"G Makshakov","year":"2017","unstructured":"Makshakov G, Magonov E, Totolyan N et al (2017) Leptomeningeal contrast enhancement is associated with disability progression and grey matter atrophy in multiple sclerosis. Neurol Res Int 2017:8652463","journal-title":"Neurol Res Int"},{"key":"13781_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/jcm8030344","volume":"8","author":"R Zivadinov","year":"2019","unstructured":"Zivadinov R, Bergsland N, Carl E et al (2019) Effect of teriflunomide and dimethyl fumarate on cortical atrophy and leptomeningeal inflammation in multiple sclerosis: a retrospective, observational, case\u2013control pilot study. J Clin Med 8:344","journal-title":"J Clin Med"},{"key":"13781_CR12","doi-asserted-by":"publisher","first-page":"104094","DOI":"10.1016\/j.msard.2022.104094","volume":"67","author":"R Zivadinov","year":"2022","unstructured":"Zivadinov R, Jakimovski D, Ramanathan M et al (2022) Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein\u2013Barr virus in multiple sclerosis. A pilot study. Mult Scler Relat Disord 67:104094","journal-title":"Mult Scler Relat Disord"},{"key":"13781_CR13","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3174\/ajnr.A5541","volume":"39","author":"R Zivadinov","year":"2018","unstructured":"Zivadinov R, Ramasamy DP, Hagemeier J et al (2018) Evaluation of leptomeningeal contrast enhancement using pre-and postcontrast subtraction 3D-FLAIR imaging in multiple sclerosis. AJNR Am J Neuroradiol 39:642\u2013647","journal-title":"AJNR Am J Neuroradiol"},{"key":"13781_CR14","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1177\/1352458516678083","volume":"23","author":"R Zivadinov","year":"2017","unstructured":"Zivadinov R, Ramasamy DP, Vaneckova M et al (2017) Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: a retrospective, pilot, observational longitudinal study. Mult Scler J 23:1336\u20131345","journal-title":"Mult Scler J"},{"key":"13781_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.105344","volume":"81","author":"S Dahal","year":"2024","unstructured":"Dahal S, Allette YM, Naunton K, Harrison DM (2024) A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis. Mult Scler Relat Disord 81:105344","journal-title":"Mult Scler Relat Disord"},{"key":"13781_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300298","volume":"19","author":"DM Harrison","year":"2024","unstructured":"Harrison DM, Allette YM, Zeng Y et al (2024) Meningeal contrast enhancement in multiple sclerosis: assessment of field strength, acquisition delay, and clinical relevance. PLoS ONE 19:e0300298","journal-title":"PLoS ONE"},{"key":"13781_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/jon.12444","volume":"27","author":"DM Harrison","year":"2017","unstructured":"Harrison DM, Wang KY, Fiol J et al (2017) Leptomeningeal enhancement at 7T in multiple sclerosis: frequency, morphology, and relationship to cortical volume. J Neuroimaging 27:461\u2013468","journal-title":"J Neuroimaging"},{"key":"13781_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519876037","author":"M Ighani","year":"2019","unstructured":"Ighani M, Jonas S, Izbudak I et al (2019) No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis. Mult Scler. https:\/\/doi.org\/10.1177\/1352458519876037","journal-title":"Mult Scler"},{"key":"13781_CR19","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3174\/ajnr.A5796","volume":"39","author":"SN Jonas","year":"2018","unstructured":"Jonas SN, Izbudak I, Frazier AA, Harrison DM (2018) Longitudinal persistence of meningeal enhancement on postcontrast 7T 3D-FLAIR MRI in multiple sclerosis. AJNR Am J Neuroradiol 39:1799\u20131805","journal-title":"AJNR Am J Neuroradiol"},{"key":"13781_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/1352458519885106","author":"J Zurawski","year":"2019","unstructured":"Zurawski J, Tauhid S, Chu R et al (2019) 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions. Mult Scler. https:\/\/doi.org\/10.1177\/1352458519885106","journal-title":"Mult Scler"},{"key":"13781_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41586-023-06993-7","volume":"627","author":"LCD Smyth","year":"2024","unstructured":"Smyth LCD, Xu D, Okar SV et al (2024) Identification of direct connections between the dura and the brain. Nature 627:165\u2013173","journal-title":"Nature"},{"key":"13781_CR22","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.29738","author":"M Absinta","year":"2017","unstructured":"Absinta M, Ha SK, Nair G et al (2017) Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI. Elife. https:\/\/doi.org\/10.7554\/eLife.29738","journal-title":"Elife"},{"key":"13781_CR23","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/brain\/awr182","volume":"134","author":"OW Howell","year":"2011","unstructured":"Howell OW, Reeves CA, Nicholas R et al (2011) Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 134:2755\u20132771","journal-title":"Brain"},{"key":"13781_CR24","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1093\/brain\/awm038","volume":"130","author":"R Magliozzi","year":"2007","unstructured":"Magliozzi R, Howell O, Vora A et al (2007) Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130:1089\u20131104","journal-title":"Brain"},{"key":"13781_CR25","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/ana.25197","volume":"83","author":"R Magliozzi","year":"2018","unstructured":"Magliozzi R, Howell OW, Nicholas R et al (2018) Inflammatory intrathecal profiles and cortical damage in multiple sclerosis. Ann Neurol 83:739\u2013755","journal-title":"Ann Neurol"},{"key":"13781_CR26","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/s41593-025-01977-4","volume":"28","author":"BA Plog","year":"2025","unstructured":"Plog BA, Kim K, Verhaege D et al (2025) A route for cerebrospinal fluid flow through leptomeningeal arterial-venous overlaps enables macromolecule and fluid shunting. Nat Neurosci 28:1436\u20131445","journal-title":"Nat Neurosci"},{"key":"13781_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.117012","volume":"219","author":"L Henschel","year":"2020","unstructured":"Henschel L, Conjeti S, Estrada S, Diers K, Fischl B, Reuter M (2020) FastSurfer\u2014a fast and accurate deep learning based neuroimaging pipeline. Neuroimage 219:117012","journal-title":"Neuroimage"},{"key":"13781_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaf254","volume":"7","author":"R Zivadinov","year":"2025","unstructured":"Zivadinov R, Bergsland N, Bartnik A et al (2025) Neuroimaging phenotype characterization of early aggressive and late severe multiple sclerosis: a case-control study. Brain Commun 7:fcaf254","journal-title":"Brain Commun"},{"key":"13781_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162\u2013173","journal-title":"Lancet Neurol"},{"key":"13781_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.neuroimage.2011.07.045","volume":"59","author":"R Zivadinov","year":"2012","unstructured":"Zivadinov R, Heininen-Brown M, Schirda CV et al (2012) Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study. Neuroimage 59:331\u2013339","journal-title":"Neuroimage"},{"key":"13781_CR31","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1212\/WNL.0b013e31820a0cc4","volume":"76","author":"JJ Geurts","year":"2011","unstructured":"Geurts JJ, Roosendaal SD, Calabrese M et al (2011) Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 76:418\u2013424","journal-title":"Neurology"},{"key":"13781_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00415-021-10833-x","volume":"269","author":"T Zrzavy","year":"2022","unstructured":"Zrzavy T, Wielandner A, Haider L et al (2022) FLAIR(2) post-processing: improving MS lesion detection in standard MS imaging protocols. J Neurol 269:461\u2013467","journal-title":"J Neurol"},{"key":"13781_CR33","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.221425","volume":"307","author":"PM Bouman","year":"2023","unstructured":"Bouman PM, Noteboom S, Nobrega Santos FA et al (2023) Multicenter evaluation of AI-generated DIR and PSIR for cortical and juxtacortical multiple sclerosis lesion detection. Radiology 307:e221425","journal-title":"Radiology"},{"key":"13781_CR34","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/jon.13088","volume":"33","author":"AR Manning","year":"2023","unstructured":"Manning AR, Beck ES, Schindler MK et al (2023) T(1) \/T(2) ratio from 3T MRI improves multiple sclerosis cortical lesion contrast. J Neuroimaging 33:434\u2013445","journal-title":"J Neuroimaging"},{"key":"13781_CR35","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1109\/TMI.2010.2046908","volume":"29","author":"NJ Tustison","year":"2010","unstructured":"Tustison NJ, Avants BB, Cook PA et al (2010) N4ITK: improved N3 bias correction. IEEE Trans Med Imaging 29:1310\u20131320","journal-title":"IEEE Trans Med Imaging"},{"key":"13781_CR36","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1002\/hbm.21402","volume":"33","author":"R Gelineau-Morel","year":"2012","unstructured":"Gelineau-Morel R, Tomassini V, Jenkinson M, Johansen-Berg H, Matthews PM, Palace J (2012) The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis. Hum Brain Mapp 33:2802\u20132814","journal-title":"Hum Brain Mapp"},{"key":"13781_CR37","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.neuroimage.2011.09.015","volume":"62","author":"M Jenkinson","year":"2012","unstructured":"Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM (2012) Fsl. Neuroimage 62:782\u2013790","journal-title":"Neuroimage"},{"key":"13781_CR38","doi-asserted-by":"publisher","unstructured":"Dwyer M, Bergsland N, Bartnik A et al (2025) Quantifying cortical lesions in large legacy multiple sclerosis clinical trial MRI datasets using multi-contrast post-processing and deep learning. medRxiv 2025;04.08.25325461. https:\/\/doi.org\/10.1101\/2025.04.08.25325461","DOI":"10.1101\/2025.04.08.25325461"},{"key":"13781_CR39","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/nimg.2002.1040","volume":"17","author":"SM Smith","year":"2002","unstructured":"Smith SM, Zhang Y, Jenkinson M et al (2002) Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 17:479\u2013489","journal-title":"Neuroimage"},{"key":"13781_CR40","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.neuroimage.2011.02.046","volume":"56","author":"B Patenaude","year":"2011","unstructured":"Patenaude B, Smith SM, Kennedy DN, Jenkinson M (2011) A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 56:907\u2013922","journal-title":"Neuroimage"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13781-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13781-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13781-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T01:48:20Z","timestamp":1776649700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13781-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["13781"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13781-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"251"}}